IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BORSARI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 808
AS - Asia 605
NA - Nord America 441
SA - Sud America 98
AF - Africa 14
OC - Oceania 4
Totale 1.970
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 438
IT - Italia 360
CN - Cina 210
SG - Singapore 206
RU - Federazione Russa 114
DE - Germania 93
BR - Brasile 84
IN - India 54
ID - Indonesia 51
SE - Svezia 43
CH - Svizzera 31
GB - Regno Unito 28
AT - Austria 26
HK - Hong Kong 20
FR - Francia 17
FI - Finlandia 16
JP - Giappone 14
NL - Olanda 14
KR - Corea 13
PT - Portogallo 13
IE - Irlanda 12
ES - Italia 8
PL - Polonia 8
MY - Malesia 7
IR - Iran 5
TR - Turchia 5
AR - Argentina 4
CO - Colombia 4
DK - Danimarca 4
MA - Marocco 4
BE - Belgio 3
BH - Bahrain 3
DZ - Algeria 3
EC - Ecuador 3
HR - Croazia 3
PK - Pakistan 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
AU - Australia 2
CZ - Repubblica Ceca 2
GR - Grecia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SI - Slovenia 2
SN - Senegal 2
UA - Ucraina 2
ZA - Sudafrica 2
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
BZ - Belize 1
CA - Canada 1
CL - Cile 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MX - Messico 1
PE - Perù 1
PS - Palestinian Territory 1
SC - Seychelles 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 1.970
Salva come PNG Salva come JPEG
Città #
Milan 144
Singapore 141
Santa Clara 125
Council Bluffs 62
Jakarta 51
Boardman 50
Monza 37
Nuremberg 35
Bengaluru 32
Beijing 29
Basel 21
Rome 17
Vienna 17
Frankfurt am Main 16
Dublin 12
Bologna 11
São Paulo 11
Guangzhou 10
Romola 10
Lappeenranta 9
Chandler 8
Hamburg 8
New York 8
Southend 8
West Jordan 8
Amsterdam 7
Helsinki 7
Kuala Lumpur 7
Lisbon 7
Columbus 6
Fairfield 6
Hong Kong 6
Los Angeles 6
Seattle 6
Shanghai 6
Warsaw 6
Ashburn 5
Berlin 5
Houston 5
Hyderabad 5
Kent 5
Wilmington 5
Edinburgh 4
Incheon 4
Neuss 4
Roccapiemonte 4
Tokyo 4
Visakhapatnam 4
Wuhan 4
Belo Horizonte 3
Bratislava 3
Braunschweig 3
Busan 3
Casale Monferrato 3
Cesano Boscone 3
Chelmsford 3
Copenhagen 3
Des Moines 3
Manama 3
Manassas 3
Medellín 3
Moscow 3
Nanjing 3
Nerima 3
Oakland 3
Porto 3
Quanzhou 3
Recife 3
Silver Spring 3
St Louis 3
Taipei 3
Tremezzina 3
Vitry-sur-seine 3
Zagreb 3
Aachen 2
Acquafredda 2
Americana 2
Ann Arbor 2
Auckland 2
Avezzano 2
Bergamo 2
Biassono 2
Bodio Lomnago 2
Cary 2
Cattolica 2
Chennai 2
Christchurch 2
Cleveland 2
Concots 2
Dakar 2
Eitensheim 2
Erdesbach 2
Eygelshoven 2
Finstadjordet 2
Forlì 2
Genoa 2
Gorgonzola 2
Granada 2
Gurugram 2
Hangzhou 2
Totale 1.135
Salva come PNG Salva come JPEG
Nome #
Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaign 180
Discovery of 1,3,4-Oxadiazole Derivatives as Broad-Spectrum Antiparasitic Agents 124
Chemo-enzymatic flow synthesis of tyrosol and hydroxytyrosol carbonates and carbamates as novel antiradical and antimicrobial agents 86
Chemo-enzymatic flow synthesis of nature-inspired phenolic carbonates and carbamates as antiradical and antimicrobial agents 83
Role of Stereochemistry on the Biological Activity of Nature-Inspired 3-Br-Acivicin Isomers and Derivatives 80
TRIAZINE DERIVATIVE AS COVALENT INHIBITORS OF PI3K 70
Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells 70
Tyrosol and hydroxytyrosol carbonates and carbamates as novel antiradical and antimicrobial agents: a chemo-enzymatic flow synthesis 63
A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3Kα 54
Chemo-enzymatic flow synthesis of nature-inspired phenolic carbonates and carbamates as antimicrobial and antiradical agents 53
Compounds having antiparasitic activity 46
METHOD FOR IDENTIFYING PI3 KINASE-ALPHA INHIBITORS 46
METHOD FOR IDENTIFYING PI3 KINASE-ALPHA INHIBITORS | [VERFAHREN ZUR IDENTIFIZIERUNG VON PI3-KINASE-ALPHA-INHIBITOREN] 46
Profiling of flavonol derivatives for the development of antitrypanosomatidic drugs 45
TRIAZINE DERIVATIVE AS REVERSIBLE AND IRREVERSIBLE COVALENT INHIBITORS OF PI3K 43
TRIAZINE DERIVATIVE AS REVERSIBLE AND IRREVERSIBLE COVALENT INHIBITORS OF PI3K | [TRIAZINDERIVAT ALS REVERSIBLE UND IRREVERSIBLE KOVALENTE PI3K-HEMMER] 39
Stereospecific Synthesis of Substituted Sulfamidates as Privileged Morpholine Building Blocks 39
Targeted Covalent Inhibitors in Drug Discovery, Chemical Biology and Beyond 38
The Facets of Diversity: The EFMC Perspective 38
YMCC and YSN: An Opportunity for Scientific and Cultural Exchange 38
Understanding Intrinsic Warhead Reactivity and Cysteine Druggability in Covalent Drug Discovery 36
(S)-4-(Difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino-1,3,5-triazin-2-yl)pyridin-2-amine (PQR530), a Potent, Orally Bioavailable, and Brain-Penetrable Dual Inhibitor of Class i PI3K and mTOR Kinase 35
TRIAZINE DERIVATIVE AS REVERSIBLE AND IRREVERSIBLE COVALENT INHIBITORS OF PI3K 32
4-(Difluoromethyl)-5-(4-((3 R,5 S)-3,5-dimethylmorpholino)-6-((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)pyridin-2-amine (PQR626), a Potent, Orally Available, and Brain-Penetrant mTOR Inhibitor for the Treatment of Neurological Disorders 31
Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives 30
Covalent Proximity Scanning of a Distal Cysteine to Target PI3Kα 28
Disease related mutations in PI3Kgamma disrupt regulatory C-terminal dynamics and reveal a path to selective inhibitors 28
Chroman-4-one derivatives targeting pteridine reductase 1 and showing anti-parasitic activity 27
Second-generation tricyclic pyrimido-pyrrolo-oxazine mTOR inhibitor with predicted blood-brain barrier permeability 27
TRIAZINE DERIVATIVE AS COVALENT INHIBITORS OF PI3K | [TRIAZINDERIVAT ALS KOVALENTE INHIBITOREN VON PI3K] 27
A Conformational Restriction Strategy for the Identification of a Highly Selective Pyrimido-pyrrolo-oxazine mTOR Inhibitor 27
Investigation of morpholine isosters for the development of a potent, selective and metabolically stable mTOR kinase inhibitor 27
TRIAZINE DERIVATIVE AS COVALENT INHIBITORS OF PI3K 26
Design, synthesis and antiparasitic evaluation of click phospholipids 26
Chemical and Structural Strategies to Selectively Target mTOR Kinase 26
Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase 25
Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity 24
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform 24
Targeting Phosphoinositide 3-Kinase – Five Decades of Chemical Space Exploration 24
METHOD FOR IDENTIFYING PI3 KINASE-ALPHA INHIBITORS 23
Development of a Focused Library of Triazole-Linked Privileged-Structure-Based Conjugates Leading to the Discovery of Novel Phenotypic Hits against Protozoan Parasitic Infections 23
Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology 22
Rapid, potent, and persistent covalent chemical probes to deconvolute PI3Kα signaling 22
SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti- Trypanosoma brucei Agent 21
null 20
Boosting the Impact of EFMC Young Scientists Network Through the Creation of Working Groups 20
Novel Dithiolane-Based Ligands Combining Sigma and NMDA Receptor Interactions as Potential Neuroprotective Agents 20
Scalable, Economical, and Practical Synthesis of 4-(Difluoromethyl)pyridin-2-amine, a Key Intermediate for Lipid Kinase Inhibitors 20
Discovery and Preclinical Characterization of 5-[4,6-Bis({3-oxa-8-azabicyclo[3.2.1]octan-8-yl})-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine (PQR620), a Highly Potent and Selective mTORC1/2 Inhibitor for Cancer and Neurological Disorders 18
Preclinical Development of PQR514, a Highly Potent PI3K Inhibitor Bearing a Difluoromethyl-Pyrimidine Moiety 18
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class i PI3K/mTOR Inhibitor as Clinical Candidate in Oncology 18
Structural Insights into the Development of Cycloguanil Derivatives as Trypanosoma brucei Pteridine-Reductase-1 Inhibitors 18
Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds 17
Discovery of a benzothiophene-flavonol halting miltefosine and antimonial drug resistance in Leishmania parasites through the application of medicinal chemistry, screening and genomics 16
Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase Case 16
X-ray crystal structures of Enterococcus faecalis thymidylate synthase with folate binding site inhibitors 15
Scaffolds and Biological Targets Avenue to Fight Against Drug Resistance in Leishmaniasis 13
Two-drug trick to target the brain blocks toxicity in the body 13
Excited-state intramolecular proton transfer in a bioactive flavonoid provides fluorescence observables for recognizing its engagement with target proteins 13
Target-based approaches for the discovery of new antimycobacterial drugs 13
YMCC and YSN: An Opportunity for Scientific and Cultural Exchange 11
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead 9
Highlights from the Lowlands: Early Career Researchers Shine at Medicinal Chemistry Frontiers 2024 6
Totale 2.216
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.254
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 0 0 0 0 7
2020/202151 2 7 0 6 5 5 4 5 7 2 8 0
2021/202239 2 2 4 8 5 0 3 2 2 0 7 4
2022/202364 4 3 2 3 3 7 4 2 5 1 25 5
2023/2024814 3 7 5 44 181 107 84 20 59 81 104 119
2024/20251.241 93 158 60 121 212 94 119 250 128 6 0 0
Totale 2.216